Jane Street’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.28M Sell
59,400
-9,900
-14% -$1.02M ﹤0.01% 3430
2025
Q4
$6.6M Sell
69,300
-55,600
-45% -$5.6M ﹤0.01% 2836
2025
Q3
$12.3M Sell
124,900
-44,800
-26% -$4.79M ﹤0.01% 2160
2025
Q2
$18.1M Buy
169,700
+90,200
+113% +$9.11M ﹤0.01% 1554
2025
Q1
$7.24M Sell
79,500
-160,900
-67% -$18M ﹤0.01% 2401
2024
Q4
$27.4M Sell
240,400
-133,800
-36% -$15.3M 0.01% 1046
2024
Q3
$44.4M Sell
374,200
-202,300
-35% -$18.6M 0.01% 746
2024
Q2
$46.3M Buy
576,500
+419,900
+268% +$38.4M 0.01% 734
2024
Q1
$14.4M Buy
156,600
+49,200
+46% +$4.72M ﹤0.01% 1465
2023
Q4
$11.3M Sell
107,400
-139,800
-57% -$14.1M ﹤0.01% 1810
2023
Q3
$26.9M Buy
247,200
+67,200
+37% +$7.43M 0.01% 884
2023
Q2
$19.4M Buy
180,000
+82,200
+84% +$9.25M 0.01% 1239
2023
Q1
$12.2M Sell
97,800
-116,300
-54% -$16M 0.01% 1444
2022
Q4
$32.2M Buy
214,100
+36,400
+20% +$5.6M 0.01% 723
2022
Q3
$24M Sell
177,700
-24,000
-12% -$3.67M 0.01% 927
2022
Q2
$30.1M Sell
201,700
-91,400
-31% -$14M 0.01% 825
2022
Q1
$50M Sell
293,100
-181,500
-38% -$30.5M 0.02% 686
2021
Q4
$122M Sell
474,600
-128,800
-21% -$35.3M 0.04% 308
2021
Q3
$165M Buy
603,400
+280,800
+87% +$89.2M 0.06% 221
2021
Q2
$72.2M Buy
322,600
+163,800
+103% +$30.9M 0.03% 406
2021
Q1
$17.3M Sell
158,800
-183,900
-54% -$19.5M 0.01% 1089
2020
Q4
$27.9M Buy
342,700
+19,900
+6% +$1.95M 0.01% 683
2020
Q3
$22.1M Buy
322,800
+276,400
+596% +$19.8M 0.01% 729
2020
Q2
$3.11M Buy
+46,400
New +$2.32M ﹤0.01% 2450

Other funds holding BNTX

Jane Street's BNTX Position: Q1 2026 in Review

Jane Street reduced its BioNTech (BNTX) stake by 75% in Q1 2026, selling an estimated $105M and leaving 336,757 shares worth $29.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1448.

Jane Street first reported a position in BNTX in Q1 2020 and has held it in 24 quarters since. The position peaked at $130M in Q4 2025. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Jane Street held 336,757 shares of BioNTech worth $29.9M as of Q1 2026.
  • Jane Street sold 1,024,464 BioNTech shares in Q1 2026, an estimated $105M.
  • BioNTech made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #1448 holding.
  • Jane Street first reported a position in BioNTech in Q1 2020 and has held it in 24 quarters since.
  • Jane Street's BioNTech position peaked at $130M in Q4 2025.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.